There are limited metrics on the perceived effectiveness and safety of cannabis use for symptom management and its dosing/mode of delivery for reducing symptoms.
Major Gaps Found in Research on Cannabis for Symptom Relief in HIV and Cancer Patients
There are limited metrics on the perceived effectiveness and safety of cannabis use for symptom management and its dosing/mode of delivery for reducing symptoms.
Cannabis for Symptom Relief in HIV and Cancer: A Map of What We Know—and What We Don’t
There are limited metrics on the perceived effectiveness and safety of cannabis use for symptom management and its dosing/mode of delivery for reducing symptoms.
Demographics, methods of use, and perceived benefits among patients with cancer who use cannabis.
The purpose of this study was to assess the demographics, reasons, methods, perceived benefits, and costs associated with the use of cannabis among patients …
Cannabis stigma and symptom management considerations in cancer survivors: a mixed-methods exploration of patient perspectives.
This study aims to assess for indications of stigma and attitudes toward cannabis among cancer survivors (CS) who use or consider the use of cannabis. This s…
Leveraging the national cancer institute’s collaborative efforts to understand the benefits and harms of cannabis use among individuals with cancer.
Cannabis use for symptom management among patients with cancer has increased significantly in recent years, with many reporting benefits for pain, anxiety, s…
Are you eligible to book a medical cannabis appointment?
Managing uncomfortable symptoms can be as much of a a demanding routine as walking your dog or taking the long commute to work. But unlike those tasks, discomfort, pain, and stressful ailments...